Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Clinical Trials Related to Myelofibrosis
Related studies linked through entity extraction aliases.
Long-Term Side Effects of Ruxolitinib in Treating Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Determine Pacritinib Pharmacokinetics in Impaired Hepatic Patients and Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia
- Status
- TERMINATED
- Phase
- PHASE2
Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT
- Status
- TERMINATED
- Phase
- PHASE1
Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders
- Status
- WITHDRAWN
- Phase
- N/A
URMC Related Haplo-identical Donor BMT
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of Vismodegib in Combination With Ruxolitinib for the Treatment of Intermediate- or High-Risk Myelofibrosis (MF)
- Status
- COMPLETED
- Phase
- PHASE1
Reduced Intensity Conditioning Transplant Using Haploidentical Donors
- Status
- COMPLETED
- Phase
- PHASE2
Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS)
- Status
- WITHDRAWN
- Phase
- PHASE1
Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia
- Status
- UNKNOWN
- Phase
- NA
Hu8F4 in Treating Patients With Advanced Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea
- Status
- COMPLETED
- Phase
- PHASE1
Ruxolitinib in Combination With Autotransplant
- Status
- WITHDRAWN
- Phase
- NA
A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Adults Receiving Ruxolitinib as Therapy for Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis With Progressive or Relapsed Disease
- Status
- TERMINATED
- Phase
- PHASE1
iCare for Cancer Patients
- Status
- TERMINATED
- Phase
- NA